Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Cramer, Jakob P; Jelinek, Tomas; Paulke-Korinek, Maria; Reisinger, Emil C; Dieckmann, Sebastian; Alberer, Martin; Bühler, Silja; Bosse, Dietrich; Meyer, Seetha; Fragapane, Elena; Costantini, Marco; Pellegrini, Michele; Lattanzi, Maria; Dovali, Claudia (2016). One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series. Journal of Travel Medicine, 23(3):taw011.

Jelinek, Tomas; Cramer, Jakob P; Dieckmann, Sebastian; Hatz, Christoph; Paulke-Korinek, Maria; Alberer, Martin; Reisinger, Emil C; Costantini, Marco; Gniel, Dieter; Bosse, Dietrich; Lattanzi, Maria (2015). Evaluation of rabies immunogenicity and tolerability following a purified chick embryo cell rabies vaccine administered concomitantly with a Japanese encephalitis vaccine. Travel Medicine and Infectious Disease, 13(3):241-250.

Hatz, Christoph; Cramer, Jakob P; Vertruyen, André; Schwarz, Tino F; von Sonnenburg, Frank; Borkowski, Astrid; Lattanzi, Maria; Hilbert, Anne Katrin; Cioppa, Giovanni Della; Leroux-Roels, Geert (2012). A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations. Vaccine, 30(32):4820-4827.

Hatz, Christoph; von Sonnenburg, Frank; Casula, Daniela; Lattanzi, Maria; Leroux-Roels, Geert (2012). A randomized clinical trial to identify the optimal antigen and MF59(®) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects. Vaccine, 30(23):3470-3477.

This list was generated on Tue Apr 23 05:20:32 2019 CEST.